Latest Breaking News On - Mirum pharmaceuticals inc - Page 3 : comparemela.com

Morgan Stanley Trims Mirum Pharmaceuticals (NASDAQ:MIRM) Target Price to $53 00

Morgan Stanley Trims Mirum Pharmaceuticals (NASDAQ:MIRM) Target Price to $53 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesNew yorkPeter radovichEric bjerkholtInsider activity at mirum pharmaceuticalsMorgan stanleySecurities exchange commissionMirum pharmaceuticals incMirum pharmaceuticals stock downColumbus asset advisorsNews ratings for mirum pharmaceuticals dailyMirum pharmaceuticals company profileSwiss national bankCantor fitzgeraldMirum pharmaceuticals

Cantor Fitzgerald Reaffirms Overweight Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)

Cantor Fitzgerald Reaffirms Overweight Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausEric bjerkholtPeter radovichMirum pharmaceuticalsMirum pharmaceuticals incSecurities exchange commissionMirum pharmaceuticals price performanceQuest partnersInstitutional investors weigh in on mirum pharmaceuticalsMirum pharmaceuticals company profileNews ratings for mirum pharmaceuticals dailyChina universal asset management coCantor fitzgeraldWetzel investment advisors incStepstone group

Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesChris peetzMirum pharmaceuticals incDrug administrationEuropean commissionHealth canadaExchange commissionMirum pharmaceuticalsDrug applicationCall detailsBreakthrough therapyFat soluble vitaminPrescribing informationImportant safetyNew drug applicationPrivate securities litigation reform act

Mirum Pharmaceuticals (MIRM) to Release Earnings on Wednesday

Mirum Pharmaceuticals (MIRM) to Release Earnings on Wednesday
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausEric bjerkholtPeter radovichMirum pharmaceuticals incSecurities exchange commissionInsider activity at mirum pharmaceuticalsMirum pharmaceuticalsCantor fitzgeraldMirum pharmaceuticals price performanceMirum pharmaceuticals company profileNews ratings for mirum pharmaceuticals dailyEarnings history for mirum pharmaceuticalsGet free reportExchange commissionMirum pharmaceuticals daily

Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC

Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAlexander miethkeHealth canadaEuropean commissionDrug administrationMirum pharmaceuticals incExchange commissionMirum pharmaceuticalsLancet gastroenterologyCincinnati childrenPam vigBreakthrough therapyFat soluble vitaminPrivate securities litigation reform act